PLAY PODCASTS
Trump may hike pharma levies to 250 per cent

Trump may hike pharma levies to 250 per cent

Squawk Box Europe Express · CNBC International

August 6, 202525m 20s

Audio is streamed directly from the publisher (dts.podtrac.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.

Show Notes

President Trump warns he could escalate pharmaceutical tariffs to as high as 250 per cent with extra levies on chips also on the table. Trump tells our colleagues Stateside, he wants to force producers to bring manufacturing home. In Europe, Novo Nordisk sees a Q2 surge driven by strong sales of its anti-obesity drug Wegovy just a week after a profit warning reduced the drug maker’s market cap by $70bn. And in banking news, Commerzbank cites restructuring costs behind its fall in Q2 net profit but the German lender is still upping key targets for the rest of the year.  

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Topics

stock market newsmarket newsKaren TsoEurope business newssquawk box podcastArabile Gumedeeurope cnbcCNBC LondonEuropean business newseurope squawk boxGeoff CutmoreCNBC podcastCNBC EuropeSteve SedgwickCNBC podcastsSquawk Box EuropeCNBC InternationalEurope newsstocksCNBCinvestingmarketsPOLITICSEconomicsmoneyFinancial MarketsSquawk BoxBusiness NewsWegovyCommerzbankPRESIDENT TRUMPU.S. TRADE TARIFFSNovo Nordiskpharmaceutical tariffs